Clinical features of uveitis in elderly patients in central Tokyo (2013-2018).


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
May 2021
Historique:
received: 18 08 2020
accepted: 09 01 2021
pubmed: 6 2 2021
medline: 22 6 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

To clarify the clinical features of uveitis in elderly patients in central Tokyo. We retrospectively identified 1424 patients with uveitis who visited the Uveitis Clinic of the University of Tokyo Hospital between January 2013 and December 2018. The patients were categorized into two groups based on their ages at the time of disease onset: patients aged 65 years or older were included in Group A, whereas those younger than 65 years were included in Group B. The etiological classification of uveitis and its causes were investigated for each group. Group A presented significantly higher rates of infectious uveitis (35.5% vs. 17.8%, p < 0.0001) and masquerade syndromes (17.9% vs. 5.0%, p < 0.0001) than Group B. Furthermore, Group A had significantly higher rates of sarcoidosis (23.1% vs. 9.3%, p < 0.0001), intraocular lymphoma (16.6% vs. 4.6%, p < 0.0001), cytomegalovirus iritis (11.0% vs. 5.6%, p = 0.0043), and cytomegalovirus retinitis (5.2% vs. 1.5%, p = 0.0020) than Group B. Our results demonstrate a clear difference in the causative diseases of uveitis between elderly and non-elderly patients. These findings may support ophthalmologists in their diagnostic process for elderly patients with uveitis.

Identifiants

pubmed: 33544350
doi: 10.1007/s10792-021-01721-4
pii: 10.1007/s10792-021-01721-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1671-1679

Références

Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI (2004) Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88:1159–1162. https://doi.org/10.1136/bjo.2003.037226
doi: 10.1136/bjo.2003.037226 pubmed: 15317708 pmcid: 1772296
Pakzad-Vaezi K, Or C, Yeh S, Forooghian F (2014) Optical coherence tomography in the diagnosis and management of uveitis. Can J Ophthalmol 49:18–29. https://doi.org/10.1016/j.jcjo.2013.10.005
doi: 10.1016/j.jcjo.2013.10.005 pubmed: 24513352
Harper TW, Miller D, Schiffman JC, Davis JL (2009) Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol 147:140-147.e2. https://doi.org/10.1016/j.ajo.2008.07.043
doi: 10.1016/j.ajo.2008.07.043 pubmed: 18834576
Nakahara H, Kaburaki T, Takamoto M, Okinaga K, Matsuda J, Konno Y, Kawashima H, Numaga J, Fujino Y, Amano S (2015) Statistical analyses of endogenous uveitis patients (2007–2009) in central Tokyo area and comparison with previous studies (1963–2006). Ocul Immunol Inflamm 23:291–296. https://doi.org/10.3109/09273948.2014.920036
doi: 10.3109/09273948.2014.920036 pubmed: 25154003
Nakahara H, Kaburaki T, Tanaka R, Takamoto M, Ohtomo K, Karakawa A, Komae K, Okinaga K, Matsuda J, Fujino Y (2017) Frequency of uveitis in the central Tokyo area (2010–2012). Ocul Immunol Inflamm 25:S8–S14. https://doi.org/10.3109/09273948.2015.1133840
doi: 10.3109/09273948.2015.1133840 pubmed: 26954613
Shirahama S, Kaburaki T, Nakahara H, Tanaka R, Takamoto M, Fujino Y, Kawashima H, Aihara M (2018) Epidemiology of uveitis (2013–2015) and changes in the patterns of uveitis (2004–2015) in the central Tokyo area: a retrospective study. BMC Ophthalmol 18:189. https://doi.org/10.1186/s12886-018-0871-6
doi: 10.1186/s12886-018-0871-6 pubmed: 30068311 pmcid: 6090933
Abaño JM, Galvante PR, Siopongco P, Dans K, Lopez J (2017) Review of epidemiology of uveitis in Asia: pattern of uveitis in a tertiary hospital in the Philippines. Ocul Immunol Inflamm 25:S75–S80. https://doi.org/10.1080/09273948.2017.1335755
doi: 10.1080/09273948.2017.1335755 pubmed: 29083984
Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S (2007) Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 51:41–44. https://doi.org/10.1007/s10384-006-0383-4
doi: 10.1007/s10384-006-0383-4 pubmed: 17295139
Ohguro N, Sonoda KH, Takeuchi M, Matsumura M, Mochizuki M (2012) The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 56:432–435. https://doi.org/10.1007/s10384-012-0158-z
doi: 10.1007/s10384-012-0158-z pubmed: 22752308
Hwang DK, Chou YJ, Pu CY, Chou P (2012) Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study. Ophthalmology 119:2371–2376. https://doi.org/10.1016/j.ophtha.2012.05.026
doi: 10.1016/j.ophtha.2012.05.026 pubmed: 22809756
Rim TH, Kim SS, Ham DI, Yu SY, Chung EJ, Lee SC; Korean Uveitis Society (2018) Incidence and prevalence of uveitis in South Korea: a nationwide cohort study. Br J Ophthalmol 102:79–83. https://doi.org/10.1136/bjophthalmol-2016-309829
doi: 10.1136/bjophthalmol-2016-309829
Uhlenberg P (2009) International handbook of population aging. Springer, Berlin
doi: 10.1007/978-1-4020-8356-3
Nakatani H (2019) Population aging in Japan: policy transformation, sustainable development goals, universal health coverage, and social determinates of health. Global Health Med 1: 3–10. https://doi.org/10.35772/ghm.2019.01011
World Health Organization (2001) Men, ageing and health: achieving health across the life span. WHO/NMH/NPH/01.2.
Jabs DA, Nussenblatt RB, Rosenbaum J, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516. https://doi.org/10.1016/j.ajo.2005.03.057
doi: 10.1016/j.ajo.2005.03.057
Suzuki Kurokawa M, Suzuki N (2004) Behcet’s disease. Clin Exp Med 4:10–20. https://doi.org/10.1007/s10238-004-0033-4
doi: 10.1007/s10238-004-0033-4 pubmed: 15598081
Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA; International Workshop on Ocular Sarcoidosis Study Group (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103:1418–1422. https://doi.org/10.1136/bjophthalmol-2018-313356
doi: 10.1136/bjophthalmol-2018-313356
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647–652. https://doi.org/10.1016/S0002-9394(01)00925-4
doi: 10.1016/S0002-9394(01)00925-4 pubmed: 11336942
Takase H, Okada AA, Goto H, Mizuki N, Namba K, Ohguro N, Sonoda KH, Tomita M, Keino H, Kezuka T, Kubono R, Mizuuchi K, Shibuya E, Takahashi H, Yanai R, Mochizuki M (2015) Development and validation of new diagnostic criteria for acute retinal necrosis. Jpn J Ophtalmol 59:14–20. https://doi.org/10.1007/s10384-014-0362-0
doi: 10.1007/s10384-014-0362-0
Holland GN (1994) Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive committee of the American Uveitis Society. Am J Ophthalmol 117:663–667. https://doi.org/10.1016/S0002-9394(14)70075-3
doi: 10.1016/S0002-9394(14)70075-3 pubmed: 8172275
Kaburaki T, Taoka K, Matsuda J, Yamashita H, Matsuda I, Tsuji H, Tanaka R, Nakazaki K, Nakamura F, Kamiya K, Kurokawa M, Ohtomo K, Aihara M (2017) Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma. Br J Haematol 179:246–255. https://doi.org/10.1111/bjh.14848
doi: 10.1111/bjh.14848 pubmed: 28699673
Cassoux N, Giron A, Bodaghi B, Tran TH, Baudet S, Davy F, Chan CC, Lehoang P, Merle-Béral H (2007) IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 48:3253–3259. https://doi.org/10.1167/iovs.06-0031
doi: 10.1167/iovs.06-0031 pubmed: 17591896 pmcid: 2078609
Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC (1997) Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 115:1157–1160. https://doi.org/10.1001/archopht.1997.01100160327010
doi: 10.1001/archopht.1997.01100160327010 pubmed: 9298057
Davis JL, Miller DM, Ruiz P (2005) Diagnostic testing of vitrectomy specimens. Am J Ophthalmol 140:822–829. https://doi.org/10.1016/j.ajo.2005.05.032
doi: 10.1016/j.ajo.2005.05.032 pubmed: 16310459
Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS, Hochberg FH (2005) Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 104:591–597. https://doi.org/10.1002/cncr.21191
doi: 10.1002/cncr.21191 pubmed: 15973665
Sugita S, Takase H, Sugamoto Y, Arai A, Miura O, Mochizuki M (2009) Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol 53:209–214. https://doi.org/10.1007/s10384-009-0662-y
doi: 10.1007/s10384-009-0662-y pubmed: 19484437
Ohta K, Sano K, Suzuki T, Hidaka E, Yoshida A, Kikuchi T (2007) B cell clonality of primary central nervous system and primary intraocular lymphomas. Jpn J Ophthalmol 51:147–149. https://doi.org/10.1007/s10384-006-0406-1
doi: 10.1007/s10384-006-0406-1 pubmed: 17401628
Ohno S, Char DH, Kimura SJ, O’Connor GR (1977) HLA antigens and antinuclear antibody titres in juvenile chronic iridocyclitis. Br J Ophthalmol 61:59–61. https://doi.org/10.1136/bjo.61.1.59
doi: 10.1136/bjo.61.1.59 pubmed: 300027 pmcid: 1042874
Liu Y, Takusagawa HL, Chen TC, Pasquale LR (2011) Fuchs heterochromic iridocyclitis and the rubella virus. Int Ophthalmol Clin 51:1–12. https://doi.org/10.1097/IIO.0b013e31822d6923
doi: 10.1097/IIO.0b013e31822d6923 pubmed: 21897135
Salah S, Abad S, Monnet D, Brézin AP (2018) Sarcoidosis. J Fr Ophtalmol 41:e451–e467. https://doi.org/10.1016/j.jfo.2018.10.002
doi: 10.1016/j.jfo.2018.10.002 pubmed: 30449643
Huh J (2012) Epidemiologic overview of malignant lymphoma. Korean J Hematol 47:92–104. https://doi.org/10.5045/kjh.2012.47.2.92
doi: 10.5045/kjh.2012.47.2.92 pubmed: 22783355 pmcid: 3389073
Fuentes E, Fuentes M, Alarcón M, Palomo I (2017) Immune system dysfunction in the elderly. An Acad Bras Cienc 89:285–299. https://doi.org/10.1590/0001-3765201720160487
doi: 10.1590/0001-3765201720160487 pubmed: 28423084
Port AD, Orlin A, Kiss S, Patel S, D’Amico DJ, Gupta MP (2017) Cytomegalovirus retinitis: a review. J Ocul Pharmacol Ther 33:224–234. https://doi.org/10.1089/jop.2016.0140
doi: 10.1089/jop.2016.0140 pubmed: 28355091
Hikita S, Sonoda K, Hijioka K, Fujimoto T, Ito T, Ishibashi T (2012) Incidence of uveitis in the northern Kyushu region of Japan - comparison between the periods of 1996–2001 and 2003–2008. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 116:847–855
Sagoo MS, Mehta H, Swampillai AJ, Cohen VM, Amin SZ, Plowman PN, Lightman S (2014) Primary intraocular lymphoma. Surv Ophthalmol 59:503–516. https://doi.org/10.1016/j.survophthal.2013.12.001
doi: 10.1016/j.survophthal.2013.12.001 pubmed: 24560125
Ogawa M, Sugita S, Shimizu N, Watanabe K, Nakagawa I, Mochizuki M (2012) Broad-range real-time PCR assay for detection of bacterial DNA in ocular samples from infectious endophthalmitis. Jpn J Ophthalmol 56:529–535. https://doi.org/10.1007/s10384-012-0174-z
doi: 10.1007/s10384-012-0174-z pubmed: 22936171
Ogawa M, Sugita S, Watanabe K, Shimizu N, Mochizuki M (2012) Novel diagnosis of fungal endophthalmitis by broad-range real-time PCR detection of fungal 28S ribosomal DNA. Graefes Arch Clin Exp Ophthalmol 250:1877–1883. https://doi.org/10.1007/s00417-012-2015-7
doi: 10.1007/s00417-012-2015-7 pubmed: 22527320
Shirahama S, Kaburaki T, Takada S, Nakahara H, Tanaka R, Komae K, Fujino Y, Kawashima H, Aihara M (2020) Comparison of visual field defect progression in secondary Glaucoma due to anterior uveitis caused by three types of herpes viruses. Graefes Arch Clin Exp Ophthalmol 258:639–645. https://doi.org/10.1007/s00417-019-04559-w
doi: 10.1007/s00417-019-04559-w pubmed: 31832767
Pasadhika S, Rosenbaum JT (2015) Ocular sarcoidosis. Clin Chest Med 36:669–683. https://doi.org/10.1016/j.ccm.2015.08.009
doi: 10.1016/j.ccm.2015.08.009 pubmed: 26593141 pmcid: 4662043
Peterson K, Gordon KB, Heinemann MH, DeAngelis LM (1993) The clinical spectrum of ocular lymphoma. Cancer 72:843–849. https://doi.org/10.1002/1097-0142(19930801)72:3%3C843::AID-CNCR2820720333%3E3.0.CO;2-#
doi: 10.1002/1097-0142(19930801)72:3%3C843::AID-CNCR2820720333%3E3.0.CO;2-# pubmed: 8334638
Berenbom A, Davila RM, Lin HS, Harbour JW (2007) Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye (Lond) 21:1198–1201. https://doi.org/10.1038/sj.eye.6702437
doi: 10.1038/sj.eye.6702437

Auteurs

Shintaro Shirahama (S)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. aphorodite.magic@gmail.com.

Hirotsugu Soga (H)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Rie Tanaka (R)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hisako Fukunaga (H)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hidetomo Izawa (H)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Keiko Komae (K)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hisae Nakahara (H)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hidetoshi Kawashima (H)

Department of Ophthalmology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-City, Tochigi, Japan.

Makoto Aihara (M)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Toshikatsu Kaburaki (T)

Department of Ophthalmology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH